Kassam Z, Lee CH
ID: 577ce47cd8307f5f80a31a81
2 Documents
Close
2 References ( articles) loading Revert Studify

Primary study

Unclassified

Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.

Authors Kassam Z , Hundal R , Marshall JK , Lee CH
Journal Archives of internal medicine
Year 2012
Links Pubmed DOI

This article is included in 5 Systematic reviews Systematic reviews (5 references)

Loading references information

Primary study

Unclassified

The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema.

blocked
Journal European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Year 2014
Links Pubmed DOI

This article is included in 5 Systematic reviews Systematic reviews (5 references)

Loading references information
Clostridium difficile infection (CDI) is one of the most frequent causes of healthcare-associated infections, and its rates are also increasing in the community. The management of CDI has become a major challenge, given growing rates of recurrences and failures with standard antibiotic therapy. Mounting evidence suggests that fecal microbiota transplantation (FMT) may be effective; however, as there is a paucity of data with regard to repeat FMT for primary non-response to this treatment, this study examined the outcome of multiple FMTs for recurrent CDI. Case records were reviewed for 94 patients who underwent FMT via retention enema for recurrent or refractory CDI during the period 2008-2012. Demographic information, treatment data, and clinical resolution rates were examined for single FMT and cumulative resolution was assessed for multiple FMTs in the context of ongoing symptoms. The cumulative clinical resolution following four or more FMTs was 86%. When antibiotic therapy was used between FMTs, the clinical resolution rate increased to 92%. There were no reported adverse events and no patients who were cured with FMT had further episodes of CDI at 6-24 months follow-up. Multiple FMTs administered through enemas is an effective, safe, and simple therapy for the management of recurrent or refractory CDI.